tiprankstipranks
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
Holding ARWR?
Track your performance easily

Arrowhead Pharmaceuticals (ARWR) Income Statement

1,468 Followers

Arrowhead Pharmaceuticals Income Statement

Last quarter (Q4 2024), Arrowhead Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Arrowhead Pharmaceuticals's net income was $-175.62M. See Arrowhead Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 3.55M$ 3.55M$ 240.74M$ 243.23M$ 138.29M$ 87.99M
Cost of Revenue
------
Gross Profit
$ 3.55M$ 3.55M$ 240.74M$ 243.23M$ 138.29M$ 87.99M
Operating Expense
$ 604.63M$ 604.63M$ 445.74M$ 421.74M$ 287.32M$ 181.15M
Operating Income
$ -601.08M$ -601.08M$ -205.00M$ -178.51M$ -149.04M$ -93.16M
Net Non Operating Interest Income Expense
$ -12.61M-$ 3.03M$ -5.03M$ 6.12M$ 9.19M
Other Income Expense
$ -20.97M$ -20.97M$ -16.84M$ 765.00K$ -2.07M$ 583.00K
Pretax Income
$ -612.46M$ -612.46M$ -206.49M$ -172.71M$ -140.85M$ -84.55M
Tax Provision
$ -2.77M$ -2.77M$ 2.78M$ 3.79M$ 2.00K$ 2.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -599.49M$ -599.49M$ -205.28M$ -176.06M$ -140.85M$ -84.55M
Basic EPS
$ -5.05$ -5.00$ -1.92$ -1.67$ -1.36$ -0.84
Diluted EPS
$ -5.05$ -5.00$ -1.92$ -1.67$ -1.36$ -0.84
Basic Average Shares
$ 479.14M$ 119.78M$ 106.75M$ 105.43M$ 103.75M$ 100.72M
Diluted Average Shares
$ 479.14M$ 119.78M$ 106.75M$ 105.43M$ 103.75M$ 100.72M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 604.63M$ 604.63M$ 445.74M$ 421.74M$ 287.32M$ 181.15M
Net Income From Continuing And Discontinued Operation
$ -599.49M$ -599.49M$ -205.28M$ -176.06M$ -140.85M$ -84.55M
Normalized Income
$ -343.31M$ -615.23M----
Interest Expense
------
EBIT
$ -599.85M$ -612.46M$ -206.49M$ -172.71M$ -140.85M$ -93.16M
EBITDA
$ -581.25M$ -593.87M$ -194.00M$ -162.29M$ -132.58M$ -87.22M
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis